In The News: School of Integrated Health Sciences

Women's Health

Have you been running with arch pain, thinking it’s not a big deal? Well take a pause, because that aching could be plantar fasciitis–which is a big deal when ignored. Plantar fasciitis occurs when the fascia, aka your foot arch, gets inflamed from the accumulation of stress overtime.

Las Vegas Review Journal

The team from the Department of Brain Health at UNLV is scheduled to discuss the latest advancements in the care and treatment of people with brain disorders.

King5

Ê×Ò³| Â鶹´«Ã½Ó³»­ 38 million Americans are caregivers for parents, spouses, adult children with disabilities, friends and other loved ones.

MedPage Today

Most ARIA cases are mild, but some have been fatal

MedPage Today

Recently approved disease-modifying treatments for Alzheimer's disease have created a sudden demand, but these and other drugs in the pipeline are not for all patients with clinical Alzheimer's symptoms, experts said.

KLAS-TV: 8 News Now

The UNLV food pantry is teaming up with Three Square to host a free food drive.

Las Vegas Review Journal

COVID-19’s latest variant is on the loose, but local experts think vaccines can mitigate its spread and severity.

MedPage Today

Looking ahead to 2024 and beyond: "There is so much more to be done"

Canadian Running Magazine

Backwards running may sound ridiculous, but studies show it has benefits for both brain and body

NeurologyLive

Over the past year, the field has experienced another significant leap of growth, powered by advances in translational research and capped off by the approval of lecanemab (Leqembi; Eisai), the first traditionally approved therapy in nearly two decades.

Daily Mail

After decades of failed trials, ineffective drugs and billions of dollars spent, a new frontier of shots offer a glimmer of hope for current and future sufferers of the cruel condition that affects 5.8million Americans.

NetworkNewsWire

The positive results are expected to form the basis for further development of Lomecel-B as a potential treatment for mild AD